发明授权
US09352025B2 Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders 有权
组合多巴胺激动剂加第一阶段胰岛素促分泌素治疗代谢紊乱

Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
摘要:
The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge.
信息查询
0/0